High Cholesterol
High Cholesterol, or Hypercholesterolemia, is a condition characterized by elevated levels of cholesterol in the blood, which can increase the risk of heart disease and stroke.
Heart Attack Treatment: EVOLocumab Study
We are studying whether adding evolocumab to standard cholesterol management helps reduce serious heart-related events in patients recently hospitalized for a heart attack. This trial aims to improve outcomes for those affected by acute myocardial infarction.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Have you been hospitalized for a heart attack (NSTEMI or STEMI) recently?
- Are you currently taking any medications to treat heart problems, like blood thinners or heart failure medications?
- Do you have any serious heart problems or conditions that could affect your safety, like severe heart failure or unstable angina?
- Are you currently pregnant, breastfeeding, or planning to become pregnant in the next 15 weeks?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Sjukhusen I Vaster-Vastra Gotalandsregionen
Kardiologiska kliniken, Södra Ringvägen 30, Alingsås Lasarett
Alingsås, Sweden
Region Gaevleborg
VO Kardiologi, Gävle Sjukhus
Gävle, Sweden
Region Joenkoepings Laen
Länssjukhuset Ryhov, Försörjningsvägen 8, medicinsk vårdenhet E
Jönköping, Sweden
Sponsor: Amgen Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.